Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.290
-0.030 (-2.27%)
At close: Jul 24, 2026, 4:00 PM EDT
1.261
-0.029 (-2.28%)
After-hours: Jul 24, 2026, 7:24 PM EDT
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $4.75 million as of July 24, 2026. Its market cap has increased by 40.27% in one year.
Market Cap
4.75M
Enterprise Value
-159.14K
1-Year Change
40.27%
Ranking
Category
Stock Price
$1.29
ChartMarket Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $135.21B to $4.75M, a decrease of -100.00%. That is a compound annual growth rate of -84.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 4.75M | 27.86% |
| Dec 31, 2025 | 3.71M | 1.92% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Soligenix | 5.46M |
| Aptevo Therapeutics | 5.45M |
| Liminatus Pharma | 5.33M |
| Dermata Therapeutics | 5.07M |
| Silo Pharma | 4.84M |
| Bio Green Med Solution | 4.83M |
| Cardio Diagnostics Holdings | 4.82M |
| Ernexa Therapeutics | 4.65M |